Medicare Enrolled
Dr. Hannah Do, M.D.
Gastroenterology · Doylestown, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Do from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Do?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Do
Dr. Hannah Do is a gastroenterology specialist in Doylestown, PA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Do performed 957 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Do received a total of $8,211 from 54 pharmaceutical and/or device companies across 473 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Do is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 16% volume in PA
$8,211 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗957
Medicare services
Top 16% in PA for gastroenterology
Not available
Unique patients (not deduplicated)
$111
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
295 | $99 | $205 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
113 | $138 | $880 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
112 | $98 | $200 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
111 | $90 | $460 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $127 | $270 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
52 | $139 | $300 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
39 | $219 | $1,012 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
35 | $63 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
25 | $107 | $275 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
22 | $185 | $750 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $71 | $145 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
14 | $79 | $410 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $88 | $180 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
12 | $129 | $934 |
| Injection beneath large bowel lining via endoscope A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine. |
12 | $13 | $900 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $132 | $290 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,211
Total received (2018-2024)
Avg $1,173/year across 7 years
Top 21% in PA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
473
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,628
2023
$1,864
2022
$871
2021
$1,164
2020
$457
2019
$941
2018
$286
Payments by company (2024)
ABBVIE INC.
$518
Takeda Pharmaceuticals U.S.A., Inc.
$277
Janssen Biotech, Inc.
$227
Medtronic, Inc.
$179
Celltrion USA Inc.
$156
GENZYME CORPORATION
$127
Lilly USA, LLC
$119
PFIZER INC.
$108
Ardelyx, Inc.
$104
Celgene Corporation
$99
IRONWOOD PHARMACEUTICALS, INC
$93
Intercept Pharmaceuticals, Inc.
$85
AIMMUNE THERAPEUTICS, INC.
$77
Madrigal Pharmaceuticals
$65
Ipsen Biopharmaceuticals, Inc
$63
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$59
Braintree Laboratories, Inc.
$45
Daiichi Sankyo Inc.
$37
Merck Sharp & Dohme LLC
$29
Meridian Bioscience Inc.
$22
Fresenius Kabi USA, LLC
$19
Phathom Pharmaceuticals, Inc.
$19
Gilead Sciences, Inc.
$18
Alnylam Pharmaceuticals Inc.
$18
QOL Medical, LLC
$17
Digestive Care, Inc.
$17
Teleflex LLC
$16
Sandoz Inc.
$15
Top 3 companies account for 38.9% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$842
Takeda Pharmaceuticals U.S.A., Inc.
$837
ABBVIE INC.
$783
Janssen Biotech, Inc.
$635
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$520
PFIZER INC.
$396
Celgene Corporation
$343
Ardelyx, Inc.
$283
GENZYME CORPORATION
$273
Gilead Sciences, Inc.
$238
Braintree Laboratories, Inc.
$237
Ferring Pharmaceuticals Inc.
$195
Ironwood Pharmaceuticals, Inc
$190
Medtronic, Inc.
$179
AbbVie, Inc.
$169
Celltrion USA Inc.
$156
Intercept Pharmaceuticals, Inc.
$140
Nestle HealthCare Nutrition Inc.
$131
Daiichi Sankyo Inc.
$125
Shionogi Inc
$122
Lilly USA, LLC
$119
AIMMUNE THERAPEUTICS, INC.
$110
Regeneron Healthcare Solutions, Inc.
$104
Merck Sharp & Dohme LLC
$100
IRONWOOD PHARMACEUTICALS, INC
$93
Merck Sharp & Dohme Corporation
$65
Madrigal Pharmaceuticals
$65
Ipsen Biopharmaceuticals, Inc
$63
Fresenius Kabi USA, LLC
$60
UCB, Inc.
$59
INTERCEPT PHARMACEUTICALS, INC.
$52
QOL Medical, LLC
$52
VIVUS, Inc.
$38
Digestive Care, Inc.
$33
NESTLE HEALTHCARE NUTRITION INC.
$33
Organon LLC
$29
Foundation Medicine, Inc.
$29
Concordia Pharmaceuticals Inc.
$27
Novartis Pharmaceuticals Corporation
$25
Amgen Inc.
$25
Lexicon Pharmaceuticals, Inc.
$23
Meridian Bioscience Inc.
$22
TESARO, Inc.
$20
AMAG Pharmaceuticals, Inc.
$19
Phathom Pharmaceuticals, Inc.
$19
Alnylam Pharmaceuticals Inc.
$18
Cook Medical LLC
$17
Pharmacosmos Therapeutics Inc.
$17
Teleflex LLC
$16
Sandoz Inc.
$15
Intra-Sana Laboratories
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Olympus America Inc.
$13
BOSTON SCIENTIFIC CORPORATION
$11
Top 3 companies account for 30.0% of all-time payments
Associated products mentioned in payments ›
AVSOLA · Amitiza · Bylvay · CIMZIA · CLENPIQ · CREON · CYLTEZO · Cimzia · DIFICID · DONNATAL · DUPIXENT · Dexilant · Donnatal · ENTYVIO · EOHILIA · Entyvio · FERAHEME · FOUNDATIONONE · GATTEX · GIVLAARI · HADLIMA · HUMIRA · HYRIMOZ · Humira · IBRANCE · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · INTERSTIM · IQIRVO · Instinct · LINZESS · Linzess · MAVYRET · MONOFERRIC · MOTEGRITY · MOTOFEN · Mavyret · Motegrity · Mulpleta · OCALIVA · OMVOH · Olympus Biliary Devices · PANCREAZE · PILLCAM · Pertzye · REBYOTA · RELTONE 200 MG · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · SOLESTA · SPYGLASS · STELARA · SUCRAID · SUFLAVE · SUTAB · TREMFYA · TRULANCE · VEGZELMA · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · Xermelo · ZEJULA · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
359
County median income
$111,951
Nearest hospital to ZIP centroid (approximate)
DOYLESTOWN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Do is a clinical cardiology specialist, with above-average Medicare volume (top 16% in PA), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Do experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Do performed 295 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Do receive payments from pharmaceutical companies?
Yes. Dr. Do received a total of $8,211 from 54 companies across 473 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Do's costs compare to other gastroenterologists in Doylestown?
Dr. Do's average Medicare payment per service is $111. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Do) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Doylestown
Browse gastroenterologists in Doylestown ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in PA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in PA
Which PA gastroenterologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology